General

Global ICU study identifies drug risk factor for patients on life support

New research involving patients in intensive care has highlighted that propofol increases cardiovascular complications risk in critically ill

Global ICU study identifies drug risk factor for patients on life support

New research involving patients in intensive care has highlighted that propofol, an anaesthetic drug commonly used to facilitate invasive mechanical ventilation, increases cardiovascular complications risk in the critically ill. 

This collaborative international study, led by Professor John Laffey at NUI Galway and researchers at the University of Milan-Bicocca, sought to understand the impact of airway management in critically ill patients. 

For verified healthcare professionals

Log in or register for free to read this article. HPN is for healthcare professionals, so new accounts are verified by our team.

Register for free Log in

Join the conversation

Comments are open to registered members. Log in or register to share your thoughts on this article.

Log in to comment Register for free